• Users Online: 91
  • Print this page
  • Email this page

    Article Cited by others


Liposomes as potential nanocarriers for theranostic applications in chronic inflammatory lung diseases

Suer Hande, Bayram Hasan

Year : 2017| Volume: 1| Issue : 1 | Page no: 1-8

   This article has been cited by
1 A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications
Hend I. Shahin, Lipika Chablani
Journal of Drug Delivery Science and Technology. 2023; : 104553
[Pubmed]  [Google Scholar] [DOI]
2 Advances and opportunities innanoimagingagents for the diagnosis of inflammatory lung diseases
Hema Brindha Masanam, Govindaraj Perumal, Saravanan Krishnan, Sachin Kumar Singh, Niraj Kumar Jha, Dinesh Kumar Chellappan, Kamal Dua, Piyush Kumar Gupta, Ashwin Kumar Narasimhan
Nanomedicine. 2023;
[Pubmed]  [Google Scholar] [DOI]
3 Prospective nanoparticle treatments for lymphangioleiomyomatosis
Emelie Landh, Roger Wang, Lyn M. Moir, Daniela Traini, Paul M. Young, Hui Xin Ong
Expert Opinion on Drug Delivery. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections
James D. Chalmers,Jakko van Ingen,Roald van der Laan,Jean-Louis Herrmann
European Respiratory Review. 2021; 30(161): 210010
[Pubmed]  [Google Scholar] [DOI]
5 A Phospholipid-Based Formulation for the Treatment of Airway Inflammation in Chronic Respiratory Diseases
Varsha Komalla,Venkata Sita Rama Raju Allam,Philip Chi Lip Kwok,Behjat Sheikholeslami,Louisa Owen,Adam Jaffe,Shafagh A Waters,Shiva Mohammad,Brian Gregory Oliver,Hui Chen,Mehra Haghi
European Journal of Pharmaceutics and Biopharmaceutics. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article